These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 12506168)

  • 1. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer.
    Hoogerbrugge N; Bult P; de Widt-Levert LM; Beex LV; Kiemeney LA; Ligtenberg MJ; Massuger LF; Boetes C; Manders P; Brunner HG
    J Clin Oncol; 2003 Jan; 21(1):41-5. PubMed ID: 12506168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer.
    Isern AE; Loman N; Malina J; Olsson H; Ringberg A
    Eur J Surg Oncol; 2008 Oct; 34(10):1148-54. PubMed ID: 18434071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved?
    Reynolds C; Davidson JA; Lindor NM; Glazebrook KN; Jakub JW; Degnim AC; Sandhu NP; Walsh MF; Hartmann LC; Boughey JC
    Ann Surg Oncol; 2011 Oct; 18(11):3102-9. PubMed ID: 21947588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
    Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
    Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations.
    Kauff ND; Brogi E; Scheuer L; Pathak DR; Borgen PI; Hudis CA; Offit K; Robson ME
    Cancer; 2003 Apr; 97(7):1601-8. PubMed ID: 12655515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
    Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
    Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk lesions in high-risk women: a high-risk formalin-based biology!
    Adem C; Jenkins RB; Capron F; Stoppa-Lyonnet D
    J Clin Oncol; 2004 Mar; 22(6):1159-61; author reply 1161-2. PubMed ID: 15020622
    [No Abstract]   [Full Text] [Related]  

  • 8. [The familial carcinoma burden and indications for subcutaneous mastectomy].
    Müller A; Tschahargane C; Schmidt W
    Dtsch Med Wochenschr; 1989 Apr; 114(15):575-9. PubMed ID: 2539289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of histopathologic findings in risk-reducing bilateral prophylactic mastectomy in patients with and without BRCA mutations.
    Boyraz B; Ly A
    Hum Pathol; 2024 Sep; 151():105534. PubMed ID: 38000681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of four-quadrant random sections in mastectomy specimens.
    Gupta D; Nath M; Layfield LJ
    Breast J; 2003; 9(4):307-11. PubMed ID: 12846866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Numerous high-risk epithelial lesions in familial breast cancer.
    Hoogerbrugge N; Bult P; Bonenkamp JJ; Ligtenberg MJ; Kiemeney LA; de Hullu JA; Boetes C; Niermeijer MF; Brunner HG
    Eur J Cancer; 2006 Oct; 42(15):2492-8. PubMed ID: 16908132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancer.
    Hermsen BB; von Mensdorff-Pouilly S; Fabry HF; Winters HA; Kenemans P; Verheijen RH; van Diest PJ
    J Pathol; 2005 Jun; 206(2):220-3. PubMed ID: 15880615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic mastectomy: pathologic findings in high-risk patients.
    Khurana KK; Loosmann A; Numann PJ; Khan SA
    Arch Pathol Lab Med; 2000 Mar; 124(3):378-81. PubMed ID: 10705389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
    Murthy V; Chamberlain RS
    Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contralateral prophylactic mastectomy.
    Rai SS; Mahabir RC; Roberts JW; Song J; Hamid KS; White RR
    Ann Plast Surg; 2011 Sep; 67(3):215-9. PubMed ID: 21508813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidental atypical proliferative lesions in reduction mammoplasty specimens in patients with a history of breast cancer.
    Li Z; Fadare O; Hameed O; Zhao C; Desouki MM
    Hum Pathol; 2014 Jan; 45(1):104-9. PubMed ID: 24182561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction.
    Rueth NM; McMahon M; Arrington AK; Swenson K; Leach J; Tuttle TM
    Ann Surg Oncol; 2011 Sep; 18(9):2515-20. PubMed ID: 21424371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of carcinoma in situ in normal and cancer-associated breasts.
    Alpers CE; Wellings SR
    Hum Pathol; 1985 Aug; 16(8):796-807. PubMed ID: 2991111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.